

Product: AI-powered, clinician-reviewed acne treatment and skin/mole assessment
Tech: Vision Transformers and large multimodal models trained on 1M+ labeled dermatology cases
Clinical model: Every AI assessment reviewed by a licensed clinician; HIPAA-compliant
Geography: U.S. rollout across 40+ states
Funding: $4.5M seed led by General Catalyst
Dermatology access and scalable skin health diagnosis/treatment
Digital health / Dermatology
$4.5M
Participation reported from SNÖ Ventures and Diede van Lamoen
“Backed by General Catalyst (lead) with participation from early-stage investors”